Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

PD-L1 antibody (AA 39-191)

This Mouse Monoclonal antibody specifically detects PD-L1 in WB, FACS, ELISA, IF, Coat and IHC (f). It exhibits reactivity toward Human.
Catalog No. ABIN6936656

Quick Overview for PD-L1 antibody (AA 39-191) (ABIN6936656)

Target

See all PD-L1 Antibodies
PD-L1 (CD274 (PD-L1))

Reactivity

  • 273
  • 142
  • 72
  • 6
  • 6
  • 5
  • 5
  • 1
  • 1
Human

Host

  • 153
  • 145
  • 20
  • 5
  • 4
  • 4
  • 2
  • 1
Mouse

Clonality

  • 203
  • 122
  • 7
Monoclonal

Conjugate

  • 157
  • 26
  • 14
  • 12
  • 9
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This PD-L1 antibody is un-conjugated

Application

  • 193
  • 145
  • 95
  • 73
  • 45
  • 45
  • 43
  • 40
  • 28
  • 15
  • 11
  • 10
  • 7
  • 6
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), ELISA, Immunofluorescence (IF), Coating (Coat), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

PDL1-2746
  • Binding Specificity

    • 71
    • 29
    • 16
    • 15
    • 14
    • 11
    • 11
    • 10
    • 7
    • 7
    • 7
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 39-191

    Specificity

    PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.

    Cross-Reactivity (Details)

    Human. Mouse.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 39-191) of human CD274 (PD-L1) protein (exact sequence is proprietary)

    Isotype

    IgG2b kappa
  • Application Notes

    Known_Application: ELISA (For coating, order antibody without BSA), Western Blot (1-2 μg/mL),Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Heart, Placenta, Spleen or Tonsil tissue. RAW, MDA-MB-231 or HepG2 cell lysates. Jurkat cells.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    PD-L1 (CD274 (PD-L1))

    Alternative Name

    CD274

    Background

    B7 homolog 1, B7-H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, Programmed cell death 1 ligand 1,PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target)
    Cellular localisation: Cell Surface and Cytoplasmic

    Molecular Weight

    37-50kDa

    Gene ID

    29126, 521989

    UniProt

    Q9NZQ7

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!